PPHvsJDOCETF Comparison
VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PPH is less expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.65% for JDOC. PPH is up 8.05% year-to-date (YTD) with -$377M in YTD flows. JDOC performs worse with 4.65% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of PPH and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PPH vs JDOC performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PPH JDOC | +4.91%+4.69% | +9.10%+8.88% | +8.05%+4.65% | +25.56%+19.42% | +44.57%n/a | +62.95%n/a |
| Flows | PPH JDOC | +$42M- | -$106M-$3M | -$377M-$34K | +$252M-$34K | +$353M- | +$396M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PPH JDOC | +20.72%+17.52% | +18.26%+14.97% | +15.76%n/a | +15.33%n/a |
| Max drawdown | PPH JDOC | -4.39%-3.99% | -10.78%-9.66% | -17.98%n/a | -20.19%n/a |
| Max drawdown duration | PPH JDOC | 16d18d | 122d154d | 434dn/a | 484dn/a |
PPH | JDOC | |
Last sale 7/24/2026 at 1:30 PM | $110.63 | $60.80 |
| Previous close 07/23/2026 | $109.95 | $60.60 |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PPH | JDOC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PPH | JDOC | |
|---|---|---|
| Last price | $110.63 | $60.80 |
| 1D performance | +0.62% | +0.32% |
| AuM | $954.80 M | $9.08 M |
| E/R | 0.36% | 0.65% |
PPH | JDOC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VanEck | J.P. Morgan Asset Management |
| Benchmark | MVIS US Listed Pharmaceutical 25 Index | - |
| N° of holdings | 25 | 61 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | November 1, 2023 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
